title: [Nitric oxide donors, a new treatment for insulin resistance, metabolic syndrome and diabetes?].
abstract: Obesity/insulin resistance ("diabesity") and the associated long term complications are reaching epidemic proportions worldwide. Recent evidence in experimental animals and humans shows that nitric oxide (NO) plays a key role in glucose and cardiovascular homeostasis. Pharmaceutical drugs releasing small and physiological amounts of NO may represent potential new treatments for insulin resistance.
authors.affiliation: Département de médecine interne et Centre Botnar de Recherche Clinique, CHUV Lausanne.
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Jayet
authors.forename: Sébastien
authors.initials: S
authors.lastname: Thalmann
authors.forename: Stéphane
authors.initials: S
authors.lastname: Cook
authors.forename: Hervé
authors.initials: H
authors.lastname: Duplain
authors.forename: Claudio
authors.initials: C
authors.lastname: Sartori
authors.forename: Peter
authors.initials: P
authors.lastname: Vollenweider
authors.forename: Urs
authors.initials: U
authors.lastname: Scherrer
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D009569:Nitric Oxide / Q000494:pharmacology; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D009765:Obesity
chemical_list: D020030:Nitric Oxide Donors; D009569:Nitric Oxide